Product Image

Memory Complex

Natrol
4.5
★ ★ ★ ★ ★
(3615 ratings)
Phosphorus 148 mg
Ginkgo
Bacopa 300 mg
Product Image
Score77
Useful bacopa and ginkgo amounts make this a credible gradual memory formula. Missing active percentages, lightly dosed supporting ingredients, and interaction concerns reduce precision.
How scoring works
Quantity:60 Tablet(s) • (30 servings)
Goals:
Mental Focus
Brain Health
Cognitive Support
Productivity Boost
Mood Support

Score 77

Useful bacopa and ginkgo amounts make this a credible gradual memory formula. Missing active percentages, lightly dosed supporting ingredients, and interaction concerns reduce precision.
How scoring works
$12.35($0.41 per serving)
iHerb
$ 12.35
Vitacost
$ 16.69
Amazon
$ 13.52
Report prices

Analysis

Bacopa extract is supplied at 300 mg and ginkgo at a commonly used daily amount, making them the most meaningful cognitive ingredients. Bacopa lacks a bacoside percentage, while the duplicate ginkgo entries make the exact marker presentation harder to interpret.

Huperzine A adds a cholinergic pathway, but its listed amount is modest, and phosphatidylserine is far below a substantial supplemental serving. B vitamins and phosphorus provide background nutrition rather than the main cognitive effect.

The formula is better suited to gradual memory and focus support than to immediate stimulant-like productivity. Reasonable value and a two-tablet serving help, but users taking medicines affected by ginkgo or cholinergic activity need extra care.

Who is it for
  • Adults seeking gradual memory and focus support
  • People who want bacopa and ginkgo in one formula
  • Users not taking anticoagulant, antiplatelet, or cholinergic medicines
Best for
  • Memory support
  • Sustained mental focus
  • Bacopa and ginkgo combination use

Pros

  • Provides 300 mg bacopa extract
  • Supplies a useful ginkgo amount
  • Includes several B vitamins
  • Offers reasonable serving value

Cons

  • Bacopa has no disclosed bacoside percentage
  • Ginkgo marker presentation is ambiguous
  • Phosphatidylserine is limited to 10 mg
  • Huperzine A is only lightly dosed

Warnings

  • Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.
  • Huperzine A may cause nausea, slowed heart rate, or vivid dreams in sensitive users.
  • Huperzine A can interact with cholinergic or anticholinergic medicines, so those combinations need clinician review.

Nutrient quality

83 Highest impact

Bacopa and ginkgo extracts name relevant marker classes, while their percentages and several vitamin forms remain unclear, and bacopa and ginkgo have meaningful extract weights, while phosphatidylserine and huperzine A are modest. The listed amounts are generally moderate, though ginkgo and huperzine A create specific interaction concerns, while bacopa, ginkgo, huperzine A, and supporting B vitamins align well with memory and cognitive support.

.

Ingredient transparency

72 High impact

Most amounts are stated, but repeated nutrient entries make several totals ambiguous, and no proprietary blend hides the amount of a listed active ingredient. Serving count is supplied, but complete daily-use directions are not provided, while inactive ingredients and excipients are not included in the supplied label details.

.

Customer satisfaction

72 High impact

The supplied average rating is favorable but below the strongest products in this group, and substantial review volume gives the average rating useful credibility. Specific review themes are unavailable, so repeated negatives and real-world fit remain uncertain.

.

Value for money

83 Highest impact

A coherent formula supports fair value despite some dose or form limitations, and the moderate serving cost is reasonable when the core formula is well disclosed. Most additions have a plausible cognitive or nutritional role, though phosphatidylserine is only token support, while the formula and serving value compare well with similar products.

.
Report analysis

Goals

Mental Focus
Mental Focus
Impact
Highest effect
A- Goal FitB Strength of SupportB+ CoverageB- Formula Quality
Folate · 680 mcg DFEVitamin B6 · 2 mgVitamin B12 · 6 mcgHuperzine · 5 mcg

Standardized ginkgo markers and a full bacopa extract amount provide a solid base for memory and sustained cognitive performance. These herbs generally work gradually rather than producing immediate stimulant-like focus.

The ginkgo marker quantities are named, but percentages and ginkgolic-acid limits are missing, while bacopa lacks a bacoside percentage. Ginkgo may raise bleeding risk with anticoagulant or antiplatelet medicines, and Huperzine A adds mild cholinergic interaction potential.

Study evidence
Bacopa Supportive 13 studies
Ginkgo Supportive 28 studies
Huperzine Not classified

No linked studies yet.

Brain Health
Brain Health
Impact
High effect
A- Goal FitB- Strength of SupportB+ CoverageB- Formula Quality
Folate · 680 mcg DFEVitamin B12 · 6 mcgVitamin B6 · 2 mgThiamin · 1.5 mgHuperzine · 5 mcgBacopa · 300 mg

Bacopa and ginkgo directly target memory and cerebral circulation, while huperzine A supports acetylcholine signaling. The main botanical evidence is relevant, but several supporting cognitive actives are supplied at very small amounts.

Bacopa and ginkgo have useful disclosed amounts and active markers, whereas phosphatidylserine and huperzine A lack functional depth. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines, and huperzine A can cause nausea, slowed heart rate, or vivid dreams.

Study evidence
Bacopa Supportive 17 studies
Ginkgo Supportive 90 studies
Huperzine Supportive 17 studies
Cognitive Support
Cognitive Support
Impact
High effect
A- Goal FitB- Strength of SupportB+ CoverageB- Formula Quality
Thiamin · 1.5 mgVitamin B6 · 2 mgFolate · 680 mcg DFEVitamin B12 · 6 mcgHuperzine · 5 mcgBacopa · 300 mg

Bacopa and ginkgo directly target memory and cerebral circulation, while huperzine A supports acetylcholine signaling. The main botanical evidence is relevant, but several supporting cognitive actives are supplied at very small amounts.

Bacopa and ginkgo have useful disclosed amounts and active markers, whereas phosphatidylserine and huperzine A lack functional depth. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines, and huperzine A can cause nausea, slowed heart rate, or vivid dreams.

Study evidence
Bacopa Supportive 30 studies
Ginkgo Supportive 87 studies
Huperzine Supportive 22 studies
Productivity Boost
Productivity Boost
Impact
High effect
B+ Goal FitC+ Strength of SupportB- CoverageC+ Formula Quality
Vitamin B12 · 6 mcgVitamin B12 · 6 mcgVitamin B6 · 2 mgHuperzine · 5 mcg

Bacopa, ginkgo, B vitamins, and Huperzine A create a broad memory and focus formula. Bacopa and ginkgo reach useful extract amounts and have relevant human evidence.

Active-marker percentages are missing, while phosphatidylserine and Huperzine A appear modest. Ginkgo may increase bleeding risk for users taking anticoagulant or antiplatelet medicines.

Study evidence
Bacopa Supportive 12 studies
Ginkgo Supportive 20 studies
Ginkgo Supportive 12 studies
Huperzine No effect 1 study
Mood Support
Mood Support
Impact
High effect
C Goal FitB+ Strength of SupportC+ CoverageC Formula Quality
Folate · 680 mcg DFEVitamin B6 · 2 mgVitamin B12 · 6 mcg

Bacopa may support stress resilience, but the product is mainly a memory formula built around ginkgo and huperzine. Mood support is secondary and indirect.

Standardized botanical markers improve disclosure, while phosphatidylserine is only lightly dosed. Ginkgo can increase bleeding risk with anticoagulants, and huperzine may interact with cholinergic or anticholinergic medicines.

Study evidence
Bacopa Supportive 7 studies

Ingredients

IngredientAmount per serving
Thiamine (Thiamine Hydrochloride)
 1.5 mg
Vitamin B3 (Niacinamide)
 20 mg
Vitamin B6 (Pyridoxine Hydrochloride)
 2 mg
Folate
680 mcg DFE
Vitamin B12 (Cyanocobalamin)
 6 mcg
Calcium (Dibasic Calcium Phosphate)
 192 mg
Phosphorus (Dibasic Calcium Phosphate)
 148 mg
Bacopa monnieri Aerial Parts Extract (Triterpene Glycosides)
 300 mg
Ginkgo biloba Leaf Extract (Ginkgo Flavone Glycosides, Terpene Lactones)
 120 mg
Phosphatidylserine Powder
10 mg
Toothed Clubmoss Extract
500 mcg
Huperzine A
5 mcg
Adults 18–50 Dairy Free Vegetarian
Report overview
Phosphorus (Dibasic Calcium Phosphate) · 148 mg OverallScore92
B Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyA+ Value

The disclosed phosphorus amount provides a practical targeted dose from a reliable mineral salt. Two tablets deliver the full serving, and the elemental amount is easy to identify. The low per-serving cost adds strong economic value, although the mineral form does not closely mirror natural bone structure.

View ingredientView products
Ginkgo (Ginkgo Flavone Glycosides, Terpene Lactones) · 120 mg OverallScore72
D- Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyB Value

The disclosed ginkgo extract amount fits the commonly used daily range, and both major active-marker classes are named. Their percentages and ginkgolic acid limits are not provided, which leaves extract quality only partly verified. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

View ingredientView products
Bacopa (Triterpene Glycosides) · 300 mg OverallScore49
D- Active Ingredient Quality & BioavailabilityD Dose, Safety & Label TransparencyB- Value

The Bacopa extract amount and aerial-part source align well with commonly used formulations. Its active bacoside yield cannot be verified because the label gives no standardization percentage or named extract. The serving is economical, but the uncertain active strength limits confidence in its value for consistent Bacopa intake.

View ingredientView products
Loading alternative details
78 Performance

Ginkgo+

NS Natural Stacks
<p>Its label clearly provides 200 mg of Panax ginseng Root Extract as Ginsenosides, making it a more clearly defined ginkgo and bacopa option. Compared with the original, its ingredient and goal alignment is stronger, although it does not retain the original product’s phosphorus coverage.</p>
75 Performance

Memoractiv

Thorne
<p>Its label clearly provides 250 mg of Acetyl-L-Carnitine as Acetyl-L-Carnitine Chloride, making it a more clearly defined ginkgo and bacopa option. Compared with the original, its ingredient and goal alignment is stronger, although it does not retain the original product’s phosphorus coverage.</p>
70 Performance

Clari-T

LifeSeasons
<p>Its label clearly provides 120 mg of Ginkgo leaf extract as Terpene Lactones, making it a more clearly defined ginkgo and bacopa option. Compared with the original, its ingredient and goal alignment is stronger, although it does not retain the original product’s phosphorus coverage.</p>
76 Budget

Pure Brainpower

Swanson
<p>Its label clearly provides 300 mg of Bacognize as Bacopa Glycosides, preserving relevant ginkgo and bacopa coverage. Compared with the original, it lowers the serving cost, although it does not retain the original product’s phosphorus coverage.</p>
77 Budget

Brain

Host Defense MycoBotanicals
<p>Its label clearly provides 120 mg of Ginkgo (Ginkgo biloba) leaf extract, preserving relevant ginkgo and bacopa coverage. It is not lower-cost than the original, but it is the closest remaining eligible fit for this category; it does not retain the original product’s phosphorus coverage.</p>
73 Budget

Neuro-Peak

ZHOU
<p>Its label clearly provides 500 mcg of Vitamin B12 as Methylcobalamin, preserving relevant ginkgo and bacopa coverage. It is not lower-cost than the original, but it is the closest remaining eligible fit for this category; it does not retain the original product’s phosphorus coverage.</p>
57 Value

ThinkFast

Futurebiotics
<p>Its label clearly provides 300 mg of CogninSA, keeping the formula relevant to ginkgo and bacopa. Compared with the original, the somewhat higher serving cost and ingredient detail create a useful quality-to-cost balance, although it does not retain the original product’s phosphorus coverage.</p>
57 Value

Think Support

Zoi Research
<p>Its label clearly provides 300 mg of Proprietary Blend, keeping the formula relevant to ginkgo and bacopa. Compared with the original, the somewhat higher serving cost and ingredient detail create a useful quality-to-cost balance, although it does not retain the original product’s phosphorus coverage.</p>
76 Value

Nu Clarity

CogniTune Smarter Health
<p>Its label clearly provides 150 mg of N-Acetyl-L Carnitine HCl, keeping the formula relevant to ginkgo and bacopa. Compared with the original, the somewhat higher serving cost and ingredient detail create a useful quality-to-cost balance, although it does not retain the original product’s phosphorus coverage.</p>
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health forGinkgo
  2. Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial.
    van Dongen M; van Rossum E; Kessels A; Sielhorst H; Knipschild P · Journal of clinical epidemiology · 2003
    Randomized trial214 participantsBrain Health forGinkgo
  3. Plant-derived nootropics and human cognition: A systematic review.
    Lorca C; Mulet M; Arévalo-Caro C; Sanchez MÁ; Perez A; Perrino M; Bach-Faig A; Aguilar-Martínez A; Vilella E; Gallart-Palau X; Serra A · Critical reviews in food science and nutrition · 2023
    Systematic review256 studies pooledBrain Health forBacopa
  4. The acute effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy normal subjects.
    Nathan PJ; Clarke J; Lloyd J; Hutchison CW; Downey L; Stough C · Human psychopharmacology · 2019
    Randomized trial38 participantsBrain Health forBacopa
  5. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  6. Is Ginkgo biloba a cognitive enhancer in healthy individuals? A meta-analysis.
    Laws KR; Sweetnam H; Kondel TK · Human psychopharmacology · 2014
    Meta-analysis1,132 participants13 studies pooledMental Focus forGinkgo
  7. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB · Human psychopharmacology · 2008
    Randomized trial78 participantsProductivity Boost forGinkgo
  8. Effects of Ginkgo biloba on alertness and chemosensory function in healthy adults.
    Mattes RD; Pawlik MK · Human psychopharmacology · 2004
    Randomized trial39 participantsProductivity Boost forGinkgo
  9. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledCognitive Support Brain Health forGinkgo
  10. Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.
    Thancharoen O; Limwattananon C; Waleekhachonloet O; Rattanachotphanit T; Limwattananon P; Limpawattana P · Drugs & aging · 2019
    Meta-analysisCognitive Support forGinkgo
  11. The cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trials.
    Pase MP; Kean J; Sarris J; Neale C; Scholey AB; Stough C · Journal of alternative and complementary medicine (New York, N.Y.) · 2012
    Systematic review6 studies pooledCognitive Support Productivity Boost forBacopa
  12. Chronic effects of Brahmi (Bacopa monnieri) on human memory.
    Roodenrys S; Booth D; Bulzomi S; Phipps A; Micallef C; Smoker J · Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2002
    Randomized trial76 participantsCognitive Support forBacopa
  13. Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis.
    Tiemtad P; Ingkaninan K; Temkitthawon P; Thimkorn P; Rattanachaisit N; Teaktong T; Dhippayom T · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
    Meta-analysis2,107 participants29 studies pooledBrain Health Mental Focus forBacopa
  14. Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract.
    Kongkeaw C; Dilokthornsakul P; Thanarangsarit P; Limpeanchob N; Norman Scholfield C · Journal of ethnopharmacology · 2014
    Meta-analysis518 participants9 studies pooledBrain Health Mental Focus Productivity Boost forBacopa
  15. Comparative efficacy of Medhya Rasayana,Bacopa monnieri, and Centella asiatica in enhancing memory and IQ of 8-10 year-old healthy boys: A prakriti-based double-blind, randomized controlled trial.
    Verma J; Rathi R; Anamika; Rathi B; Pandey VB · Journal of Ayurveda and integrative medicine · 2025
    Randomized trial180 participantsBrain Health Cognitive Support forBacopa
  16. The effect of plant active substances on cognitive function in healthy older adults: a systematic review and network meta-analysis of randomized controlled trials.
    Feng X; Fan S; Wei F · Frontiers in pharmacology · 2026
    Meta-analysis1,861 participants25 studies pooledBrain Health Cognitive Support forBacopa
  17. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledBrain Health Productivity Boost forGinkgo
  18. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  19. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  20. Huperzine a in the treatment of Alzheimer's disease and vascular dementia: a meta-analysis.
    Xing SH; Zhu CX; Zhang R; An L · Evidence-based complementary and alternative medicine : eCAM · 2014
    Meta-analysis825 participants10 studies pooledBrain Health Cognitive Support forHuperzine
  21. [Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial].
    Zhang Z; Wang X; Chen Q; Shu L; Wang J; Shan G · Zhonghua yi xue za zhi · 2002
    Randomized trial202 participantsBrain Health Cognitive Support forHuperzine
  22. Huperzine A associated with improved early postoperative cognitive function after neurosurgery under general anesthesia: a randomized clinical trial.
    Zhang Z; Shen Y; Li J; Tang Y; Zhou P; Ying T; Mo R; Ru Z; Zhao G; Zhu J; Li S; Zhao H · International journal of surgery (London, England) · 2026
    Randomized trial123 participantsBrain Health Cognitive Support forHuperzine
  23. Treatment with Huperzine A improves cognition in vascular dementia patients.
    Xu ZQ; Liang XM; Juan-Wu; Zhang YF; Zhu CX; Jiang XJ · Cell biochemistry and biophysics · 2012
    Randomized trial78 participantsBrain Health forHuperzine
  24. Huperzine-A response to cognitive impairment and task switching deficits in patients with Alzheimer's disease.
    Gul A; Bakht J; Mehmood F · Journal of the Chinese Medical Association : JCMA · 2019
    Randomized trial100 participantsBrain Health forHuperzine
  25. A systematic review of the Ayurvedic medicinal herb Bacopa monnieri in child and adolescent populations.
    Kean JD; Downey LA; Stough C · Complementary therapies in medicine · 2017
    Systematic review5 studies pooledCognitive Support forBacopa
  26. Efficacy of Standardized Extract of Bacopa monnieri (Bacognize®) on Cognitive Functions of Medical Students: A Six-Week, Randomized Placebo-Controlled Trial.
    Kumar N; Abichandani LG; Thawani V; Gharpure KJ; Naidu MU; Venkat Ramana G · Evidence-based complementary and alternative medicine : eCAM · 2024
    Randomized trial60 participantsCognitive Support forBacopa
  27. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  28. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support Productivity Boost forGinkgo
  29. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  30. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  31. Adjunctive huperzine A for cognitive deficits in schizophrenia: a systematic review and meta-analysis.
    Zheng W; Xiang YQ; Li XB; Ungvari GS; Chiu HF; Sun F; D'Arcy C; Meng X; Xiang YT · Human psychopharmacology · 2017
    Meta-analysis1,117 participants12 studies pooledCognitive Support forHuperzine
  32. [Drug evaluation of huperzine A in the treatment of senile memory disorders].
    Zhang RW; Tang XC; Han YY; Sang GW; Zhang YD; Ma YX; Zhang CL; Yang RM · Zhongguo yao li xue bao = Acta pharmacologica Sinica · 1992
    Randomized trial56 participantsCognitive Support forHuperzine
  33. Evaluating the effects of Bacopa monnieri on cognitive performance and sleep quality of patients with mild cognitive impairment: A triple-blinded, randomized, placebo-controlled trial.
    Delfan M; Kordestani-Moghaddam P; Gholami M; Kazemi K; Mohammadi R · Explore (New York, N.Y.) · 2024
    Randomized trial62 participantsMental Focus forBacopa
  34. Cognitive effects of two nutraceuticals Ginseng and Bacopa benchmarked against modafinil: a review and comparison of effect sizes.
    Neale C; Camfield D; Reay J; Stough C; Scholey A · British journal of clinical pharmacology · 2013
    Systematic reviewMental Focus forBacopa
  35. Efficiency of Different Supplements in Alleviating Symptoms of ADHD with or Without the Use of Stimulants: A Systematic Review.
    Al Shahab S; Al Balushi R; Qambar A; Abdulla R; Qader M; Abdulla S; Jahrami H · Nutrients · 2025
    Systematic reviewMental Focus forBacopa
  36. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  37. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  38. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  39. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  40. The Effects of a Bacopa monnieri Extract (Bacumen®) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Lopresti AL; Smith SJ · Clinical drug investigation · 2025
    Randomized trial101 participantsMood Support forBacopa
  41. Effects of Bacopa monnieri (CDRI 08®) in a population of males exhibiting inattention and hyperactivity aged 6 to 14 years: A randomized, double-blind, placebo-controlled trial.
    Kean JD; Downey LA; Sarris J; Kaufman J; Zangara A; Stough C · Phytotherapy research : PTR · 2022
    Randomized trial112 participantsMood Support forBacopa
  42. The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects.
    Stough C; Lloyd J; Clarke J; Downey LA; Hutchison CW; Rodgers T; Nathan PJ · Psychopharmacology · 2001
    Randomized trial85 participantsMood Support forBacopa
  43. Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial.
    Calabrese C; Gregory WL; Leo M; Kraemer D; Bone K; Oken B · Journal of alternative and complementary medicine (New York, N.Y.) · 2009
    Randomized trial54 participantsMood Support Productivity Boost forBacopa
  44. Brahmi for the better? New findings challenging cognition and anti-anxiety effects of Brahmi (Bacopa monniera) in healthy adults.
    Sathyanarayanan V; Thomas T; Einöther SJ; Dobriyal R; Joshi MK; Krishnamachari S · Psychopharmacology · 2013
    Randomized trial72 participantsMood Support forBacopa
  45. Examining the nootropic effects of a special extract of Bacopa monniera on human cognitive functioning: 90 day double-blind placebo-controlled randomized trial.
    Stough C; Downey LA; Lloyd J; Silber B; Redman S; Hutchison C; Wesnes K; Nathan PJ · Phytotherapy research : PTR · 2009
    Randomized trial107 participantsProductivity Boost forBacopa
  46. An acute, double-blind, placebo-controlled crossover study of 320 mg and 640 mg doses of a special extract of Bacopa monnieri (CDRI 08) on sustained cognitive performance.
    Downey LA; Kean J; Nemeh F; Lau A; Poll A; Gregory R; Murray M; Rourke J; Patak B; Pase MP; Zangara A; Lomas J; Scholey A; Stough C · Phytotherapy research : PTR · 2014
    Randomized trial24 participantsProductivity Boost forBacopa
  47. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo
  48. Dietary Flavonoids and Human Cognition: A Meta-Analysis.
    Cheng N; Bell L; Lamport DJ; Williams CM · Molecular nutrition & food research · 2022
    Meta-analysis5,519 participants80 studies pooledProductivity Boost forGinkgo
  49. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE · Journal of psychopharmacology (Oxford, England) · 2005
    Randomized trial87 participantsProductivity Boost forGinkgo
  50. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N; GIMCIPlus Study Group · International journal of geriatric psychiatry · 2015
    Randomized trial160 participantsProductivity Boost forGinkgo
  51. Effect of Huperzine A on Cognitive Function and Perception of Effort during Exercise: A Randomized Double-Blind Crossover Trial.
    Wessinger CM; Inman CL; Weinstock J; Weiss EP · International journal of exercise science · 2025
    Randomized trial15 participantsProductivity Boost forHuperzine